Filariasis epidemiology and demographics

Revision as of 17:00, 3 July 2017 by Ahmed Younes (talk | contribs)
Jump to navigation Jump to search

Filariasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Filariasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Filariasis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Filariasis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Filariasis epidemiology and demographics

on Filariasis epidemiology and demographics

Filariasis epidemiology and demographics in the news

Blogs on Filariasis epidemiology and demographics

Directions to Hospitals Treating Filariasis

Risk calculators and risk factors for Filariasis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Lymphatic filariasis is widely distributed all over the world and affects as many as 120 million individual worldwide. It is also responsible for disability in about 40 million patient. It affects children below 5 years and the probability of infection increases by age. The causative worms are more found in the tropical areas, Asia and Africa.

Epidemiology and Demographics

Prevalence

  • Lymphatic filariasis affects over 120 million people and it has been the leading causes of disability among filariasis patients.[1]
  • It has been reported that billion people are at risk of being infected with the disease.[2]
  • Filariasis causes disability in 40 million of the patients.[3]
  • The prevelance of bancrofti filariasis (filariasis caused by W. Bancrofti) is 90,000 per 100,000 individual.

Age

  • Filariasis commonly affects children before age of 5 more than the adults but infection probability increases by age.
  • It affects children before age of 5 years but they remain asymptomatic and the symptoms appear after the puberty.[2]

Gender

  • Men and women are affected equally by filariasis.

Race

  • There is no racial predilection for filariasis.

Geographic Distribution

  • Distribution of the different nematodes causing lymphatic filariasis as the following:
  • In endemic areas of the world (e.g., Malaipea in Indonesia), up to 54% of the population may have microfilariae in their blood.[4] In the Americas, only four countries are currently known to be endemic: Haiti, the Dominican Republic, Guyana and Brazil.

References

  1. "Global programme to eliminate lymphatic filariasis: progress report, 2013". Wkly Epidemiol Rec. 89 (38): 409–18. 2014. PMID 25243263.
  2. 2.0 2.1 Witt C, Ottesen EA (2001). "Lymphatic filariasis: an infection of childhood". Trop Med Int Health. 6 (8): 582–606. PMID 11555425.
  3. "Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010". Wkly Epidemiol Rec. 86 (35): 377–88. 2011. PMID 21887884.
  4. Aupali T, Ismid IS, Wibowo H; et al. (2006). "Estimation of the prevalence of lymphatic filariasis by a pool screen PCR assay using blood spots collected on filter paper". Tran R Soc Trop Med Hyg. 100 (8): 753&ndash, 9.


Template:WikiDoc Sources